Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07541521Recruiting

RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC

Role: collaborator

NCT07528066Recruiting

Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC

Role: collaborator

NCT02843243Terminated

Validation of Different Risk Assessment Strategies in Normotensive Pulmonary Embolism

Role: lead

NCT03339063Unknown

The Italian REgistry of Pulmonary Non-tuberculous mycobactEria

Role: collaborator

All 4 trials loaded